Anqi Xue

611 citations
9 papers · 475 indexed · 1 hit paper · h-index 7
Topics
Nanoplatforms for cancer theranostics (3 papers)Photodynamic Therapy Research Studies (2 papers)Molecular Sensors and Ion Detection (1 paper)
Partner nations
ChinaAustraliaMontenegro

In The Last Decade

Anqi Xue

8 papers receiving 471 citations

Hit Papers

Elimination of senescent cells by β-galactosidase-targete...2020202620222024202050100150200250

Peers

Anqi Xue
Comparison fields: 5 of 82
  • Molecular Biology 205
  • Physiology 148
  • Biomedical Engineering 111
  • Materials Chemistry 91
  • Immunology 60
Replace Xiongbin Chen with:
Xiongbin Chen China
Chenxia He China
Ayswaria Deepti India
Denise Oró Denmark
Zhipeng Tao United States
Forough Alemi Iran
Cuilan Hou China
Linxi Chen China
Anqi Xue relative to Xiongbin Chen China Xiongbin Chen's profile →
Citations per field
00.5×7.4×
Xiongbin Chen · 1×
Citations per year

Countries citing papers authored by Anqi Xue

Since Specialization
Citations

This map shows the geographic impact of Anqi Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anqi Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anqi Xue more than expected).

Fields of papers citing papers by Anqi Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anqi Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anqi Xue. The network helps show where Anqi Xue may publish in the future.

Co-authorship network of co-authors of Anqi Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Anqi Xue. A scholar is included among the top collaborators of Anqi Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anqi Xue. Anqi Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 0
2 15
3 29
4 12
5 25
6
Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged micebreakdown →
284
7 3
8 25
9 82

About Anqi Xue

Anqi Xue is a scholar working on Bioengineering, Immunology and Allergy and Electrochemistry, having authored 9 papers that have together received 475 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (3 papers), Photodynamic Therapy Research Studies (2 papers) and Molecular Sensors and Ion Detection (1 paper). The work is most often cited by research in Aging (24 citations), Physiology (148 citations) and Inorganic Chemistry (47 citations). Anqi Xue has collaborated with scholars based in China, Australia and Montenegro. Frequent co-authors include Cheng Li, Hongkui Deng, Tuoping Luo, Qi Sun, Yin Ji, Han Chen, Yuting Wang, Yinhua Zhu, Wenhan Chen and Huanhuan Zhou. Their work appears in journals such as Nature Communications, Inorganic Chemistry and RSC Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026